Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

In Vivo Study of Safety, Tolerability and Dosing Effect on SMN mRNA and Protein Levels of Valproic Acid in Patients With Spinal Muscular Atrophy

NCT00374075 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.

NCT NCT00374075
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00374075 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
In Vivo Study of Safety, Tolerability and Dosing Effect on SMN mRNA and Protein Levels of Valproic Acid in Patients With Spinal Muscular Atrophy
Lead sponsor
University of Utah
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2003
Completion date
February 28, 2006
Enrollment
42
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

spinal muscular atrophy